AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Missouri

HB951

Modifies provisions relating to alternative therapies and treatments, including psilocybin

Status

Did not pass; died when the session ended

2025 Session

IntroducedJan 21, 2025 (done)
PassedDid not happen (skipped)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Matthew Overcast (Republican)
Type: Regulation
Substances: Psilocybin

Official text

Summary (from PoliPsy)

Modifies provisions relating to alternative therapies and treatments, including psilocybin

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: house.mo.gov

Legislative history

May 15, 2025
Referred
May 15, 2025
Referred
January 21, 2025
Introduced

Loading bill…